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Abstract
Background: Glucocorticoids (GCs) measured in neonatal hair might reflect intrauterine as 
well as postpartum GC regulation. We aimed to identify factors associated with neonatal 
hair GC levels in early life, and their correlation with maternal hair GCs.
Methods: In a single-center observational study, mother–infant pairs (n = 107) admitted 
for >72 h at the maternity ward of a general hospital were included. At birth and an 
outpatient visit (OPV, n = 72, 44 ± 11 days postpartum), maternal and neonatal hair was 
analyzed for cortisol and cortisone levels by LC–MS/MS. Data were analyzed regarding: (1) 
neonatal GC levels postpartum and at the OPV, (2) associations of neonatal GC levels with 
maternal GC levels and (3) with other perinatal factors.
Results: (1) Neonatal GC levels were >5 times higher than maternal levels, with a decrease 
in ±50% between birth and the OPV for cortisol. (2) Maternal and neonatal cortisol, but 
not cortisone, levels were correlated both at postpartum and at the OPV. (3) Gestational 
age was associated with neonatal GC postpartum (log-transformed β (95% CI): cortisol 0.07 
(0.04–0.10); cortisone 0.04 (0.01–0.06)) and at the OPV (cortisol 0.08 (0.04–0.12); cortisone 
0.00 (−0.04 to 0.04)), while weaker associations were found between neonatal GCs and 
other perinatal and maternal factors.
Conclusions: Neonatal hair GCs mainly reflect the third trimester increase in cortisol, 
which might be caused by the positive feedback loop, a placenta-driven phenomenon, 
represented by the positive association with GA. Between birth and 1.5 months 
postpartum, neonatal hair cortisol concentrations decrease sharply, but still appear to 
reflect both intra- and extrauterine periods.
Introduction
Prenatal exposure to excessive glucocorticoids (GCs) has been 
associated with an increased risk of cardiovascular diseases and 
depressive disorders (1, 2). This might be due to permanent 
alterations in the settings of the fetal hypothalamic–pituitary–
adrenal (HPA) axis, which are protective in the short term, but 
might pose a risk in the long term (3).
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The development of the fetal HPA axis is, among other 
factors, influenced by the placental transfer of maternal 
GCs throughout pregnancy (4). During early gestation, 
maternal GCs are the main supply. By the second half of 
gestation, the fetal adrenal starts producing its own steroids, 
predominantly sex steroids (which serve as a substrate for 
the placental production of estriol) and precursor GCs, 
since the adrenocortical enzymes are not fully matured yet 
(5). Subsequently, during the last 6–8 weeks of pregnancy, 
the more matured fetal adrenal produces increasing 
amounts of cortisol and cortisone under the control of 
corticotropic-releasing hormone (CRH) production in the 
placenta, which – in contrast to the negative feedback loop 
between cortisol and CRH under non-pregnant conditions 
– establishes a positive feedback loop (6). This increase in 
cortisol concentration promotes maturation of the fetal 
lungs as well as of other organs (7).
Knowledge on the fetal HPA axis development is 
mainly based on animal studies (5, 8), as it is difficult to 
measure fetal HPA axis activity in humans. Up till now, 
amniotic fluid GC levels and umbilical cord GC levels 
have been used to assess intrauterine GC regulation. 
Cortisol in amniotic fluid has previously been correlated 
with maternal cortisol levels (9) and onset of labor 
(10). However, the source of amniotic fluid cortisol 
remains uncertain, although findings point toward fetal 
production (11, 12). In addition, sampling of amniotic 
fluid is a stressful occasion and only provides cross-
sectional information. Alternatively, umbilical cord blood 
can be drawn non-invasively, but GC levels are influenced 
by delivery (13) and might not reflect normal intrauterine 
HPA axis activity. GCs measured in scalp hair might offer 
a solution, as it is used as a measure for HPA axis activity 
over time without the disturbing influence of the circadian 
rhythm. The hair GC concentrations reflect the exposure 
in the time frame during which the hair grows (14).
Maternal hair GC levels seem to reflect HPA axis activity 
during pregnancy (15, 16, 17). Neonatal hair GC levels 
have also been associated with pre- and perinatal factors. 
A recent study by Hoffman and coworkers (18) has shown 
that gestational age as well as birth weight had a positive 
association with cortisol levels in neonatal hair. Neonatal 
hair GC levels were also significantly higher than maternal 
hair GC levels. This study suggests that features of the fetal 
adrenal development are represented in neonatal hair GC 
levels, although these findings are limited due to the fact 
that this has only been described in one study population, 
cortisone levels were not taken into account and the course 
followed by GC levels in hair postpartum has not been 
studied.
Therefore, we aimed to describe cortisol and cortisone 
concentrations in neonatal hair, obtained directly 
postpartum, and their relation with maternal hair GC 
levels and pre- and perinatal factors. Finally, we explored 
the differences in hair GC concentrations between birth 
and an outpatient visit (OPV) at approximately 6 weeks 
postpartum, as well as which factors are of influence on 
this difference.
Methods
Population
From February 2012 to August 2013, mother–infant pairs 
were included in the OLVG West Hospital in Amsterdam, 
The Netherlands. Subjects were informed regarding the 
study before or within 24 h after delivery. The infant 
needed to be admitted to the hospital (maternity ward 
or neonatal care unit) for at least 72 h for a neonatal or 
maternal reason, as this was an inclusion criterion for a 
simultaneous study (19). Subjects were excluded for the 
following reasons: (1) insufficient knowledge of the Dutch 
or English language, (2) mental retardation of one or both 
parents, (3) multiple pregnancy, (4) use of illicit drugs or 
regular (>2 IU/week) alcohol use during the last trimester, 
(5) use of systemic corticosteroids during pregnancy, (6) 
if participating in this study would interfere with regular 
care or (7) use of psychotropic medication.
The study was approved by the medical ethics 
committees of the OLVG West Hospital and the 
VU University Medical Center in Amsterdam, The 
Netherlands. Written informed consent was obtained 
from all participants.
Determinants
The mother filled in a questionnaire about demographic 
characteristics.
Information on perinatal characteristics and the 
reasons for admission to the hospital were obtained from 
medical records.
Hair cortisol measurements
On the first day, postpartum neonatal hair was cut from 
the posterior vertex of the scalp, as close as possible to 
the scalp, as this region shows the least variance between 
different strands (14). At the OPV around 6  weeks, 
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postpartum neonatal hair was collected again. The total 
length of hair directly postpartum was analyzed, with the 
assumption that it is an indication of GC concentrations 
during fetal life, while at the OPV, only the centimeter of 
hair closest to the scalp was analyzed, with the assumption 
that it gives an indication of GC concentrations during 
the first weeks of life (20, 21).
Maternal hair was also collected on the first day 
postpartum and at the OPV. Only the centimeter closest 
to the scalp of maternal hair was analyzed. As, in adults, 
hair grows approximately 1 cm every month (16, 20, 21), 
the hair measurement postpartum is indicative for the GC 
levels during the last month of pregnancy.
GC levels (cortisol and cortisone) were measured in 
hair as previously described (20). In short, in the presence 
of deuterium-labeled GCs as the internal standard, 
cortisol was extracted using LC-grade methanol at 25°C 
for 18 h. These extracts were subsequently centrifuged and 
cleaned using solid phase extraction. GC concentrations 
were quantified by liquid chromatography–tandem 
mass spectrometry LC–MS/MS (Waters XEVO-TQ-S 
system, Waters Corporation, Milford, MA, USA). GC 
concentrations were reported as pg per mg hair, and 
1.25 mg was required for a reliable measurement.
Statistics
Analyses were performed with regard to:
1. Concentrations of GCs in neonatal hair directly 
postpartum and at the OPV. GC levels were expressed 
as median (range). Subsequently, GC levels were log-
transformed and paired t-tests were performed.
2. The relation between maternal and neonatal (log-
transformed) hair GC levels postpartum and at the OPV 
was assessed using Pearson correlation coefficients and 
linear regression.
3. Factors associated with neonatal hair GCs directly 
postpartum were assessed using linear regression. 
Additional analyses were performed to assess the 
effect of the factors associated with GC levels directly 
postpartum on the course of GC levels (expressed as 
delta cortisol and cortisone) and on the GC levels at 
the OPV, corrected for age at the time of sampling. 
The following factors, based on literature (15, 16, 
17, 18), were taken into consideration: (a) perinatal: 
gestational age, birth weight (in kg and S.D. score), 
sex, mode of delivery, perinatal infection, respiratory 
distress (meconium-containing amniotic fluid, 
respiratory insufficiency, respiratory support, persistent 
pulmonary hypertension of the neonate); (b) maternal: 
age, ethnicity, maternal smoking, parity (primi- vs 
multipara), hypertensive disorders (pregnancy-
induced hypertension, pre-existent hypertension, pre-
eclampsia/HELLP syndrome (hemolysis, elevated liver 
enzymes and low platelet count)). 
Results with a P-value <0.05 were considered 
to be statistically significant, although borderline 
statistically significant results (0.10 > P > 0.05) when 
found for both cortisol and cortisone were also further 
explored.
Results
Population
A total of 107 mother–infant pairs donated hair directly 
postpartum. At the OPV, 72 mother–infant pairs donated 
hair. The OPV took place at 44 ± 11 days postpartum (range: 
22–87  days). Perinatal and demographic characteristics 
are presented in Table 1.
Concentration of GCs in neonatal hair Results 
are displayed in Fig. 1 and Table 2. Directly postpartum, 
the median concentration of cortisol was 169 pg/mg 
(range: 51–1294), while the median concentration 
of cortisone was 85 pg/mg (range: 23–597). Maternal 
GC levels were much lower than neonatal levels, with 
median concentrations of 5 (range: 0–672) and 18 
(2–87) pg/mg respectively.
Course of GC levels postpartum Between birth and 
the OPV, a steep decrease in cortisol concentrations in 
infant hair was observed (Fig.  1 and Table  2). Maternal 
hair cortisol levels showed a subtle decrease between 
birth and the OPV. In contrast, infant and maternal hair 
cortisone levels remained stable, although a wide range 
of values were observed. At the OPV, both infant cortisol 
and cortisone concentrations were still higher than the 
GC levels in maternal hair. Age of the neonate at the 
OPV was negatively associated with hair cortisol, but 
not with cortisone levels (log-transformed β (95% CI): 
cortisol −0.01 (−0.02 to −0.001), P = 0.03; cortisone: 0.00 
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(−0.01 to 0.01), P = 0.70). Age of the neonate at the OPV 
was not associated with delta cortisol or cortisone.
Correlations with maternal hair GCs Directly 
postpartum, maternal and neonatal hair cortisol were 
positively associated (n = 107, r = 0.336, β 0.23 (95% CI: 
0.11–0.36), P < 0.001), while no correlations were found 
between maternal and infant hair cortisone (P = 0.66). At 
the OPV, the association between maternal and infant 
hair cortisol was stronger than directly postpartum (n = 71, 
r = 0.457, β 0.41 (95% CI: 0.22–0.60), P < 0.001), and no 
correlation was found for cortisone (P = 0.12).
Factors associated with neonatal hair GCs The 
effect of several perinatal and maternal factors on hair GC 
levels measured directly postpartum was studied (Table 
3). Gestational age was strongly associated with both 
cortisol and cortisone levels, as illustrated in Fig. 1, and 
this association remained significant when only term-
born infants (n = 98) were studied. Additionally, there was 
a positive association for both cortisol and cortisone levels 
with perinatal infection (defined as the need for treatment 
with antibiotics for ≥7 days). Birth weight was associated 
with both cortisol and cortisone when expressed in 
kilograms, but this association was lost when birth weight 
was expressed as the s.d. score. Moreover, delivery via 
cesarian section was associated with both lower cortisol 
and cortisone levels, while multiparity was associated 
with lower cortisol levels.
Next, the effect of the (borderline) significant 
factors on the course of GC levels was studied (Table 4). 
Gestational age was associated with a trend toward a 
steeper decrease in cortisol and cortisone between birth 
and the OPV. Additionally, perinatal infection was 
associated with a steeper decrease in cortisone, while 
delivery via cesarian section was associated with a smaller 
decrease in cortisone.
Finally, the effect of these factors on the GC levels at 
the OPV was analyzed (Table 4). Gestational age was still 
positively associated with infant hair cortisol levels, but 
not with cortisone. Additionally, males had higher cortisol 
levels in hair at the OPV, but no association was found 
with cortisone. The other factors were not associated with 
OPV hair GC levels.
Discussion
In this study, we have described the levels of cortisol and 
cortisone in neonatal hair, both directly postpartum, 
as well as at an OPV at 44 ± 11  days postpartum. GC 
levels in neonatal hair directly postpartum seem to 
Table 1 Baseline characteristics of the study population 
(n = 107).
 Mean ± s.d., median (range) or n (%)
Perinatal  
 Gestational age 39.5 ± 1.8, 39.5 (33.9–42.1)
 Birth weight 3480 ± 629, 3569 (1806–5290)
 Male sex 61 (55.5)
 Vaginal delivery 40 (32.5)
 Perinatal infection 34 (30.9)
 Respiratory problems 9 (8.2)
Maternal  
 Age 33.9 ± 4.8, 34 (21–44)
 Non-Dutch ethnicity 52 (47.3)
 Smoking 2 (1.8)
 Nulliparae 67 (54.5)
 Hypertensive disorders 7 (6.4)
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Figure 1
Neonatal hair cortisol (A) and cortisone (B) levels measured directly 
postpartum (dark circle) and at the OPV (light circle).
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reflect intrauterine GC exposure. GC levels in neonatal 
hair  are much higher than maternal levels and appear 
to be influenced mainly by gestational age, possibly 
reflecting the normal prenatal increase in endogenous 
fetal cortisol. After birth, cortisol levels decrease 
sharply, although at the OPV, neonatal levels are still 
much higher compared to maternal levels. This suggests 
that at that time point, GC levels represent the intra- 
and extrauterine period, since GC levels in infants are 
not markedly different from maternal cortisol levels 
(22, 23). Additionally, at birth, neonatal hair GC levels 
are associated with other perinatal factors such as 
perinatal infection, although to a lesser degree than 
gestational age.
In our study, we could confirm the association 
described by Hoffmann and coworkers (18) between 
neonatal hair cortisol levels and both gestational age 
and birth weight directly postpartum. However, we did 
not find an association with birth weight SDS. Since 
birth weight and gestational age are correlated, the 
association with birth weight probably reflects the effect 
of gestational age rather than of intrauterine growth. 
The association with gestational age might be indicative 
of several mechanisms. First, adrenal maturation occurs 
throughout pregnancy, resulting in increased cortisol 
production by the fetal adrenal (5). A higher concentration 
of GCs in hair might therefore reflect a longer exposure 
to the maturing HPA axis. However, since the association 
Table 2 Concentrations of neonatal and maternal hair glucocorticoid concentrations postpartum and at the outpatient visit.
  Postpartum (median, range (pg/mg)) (n = 107) Outpatient visit (median, range (pg/mg)) (n = 72) P value*
Infant Cortisol 169, 51–1294 71, 2–479 <0.001
 Cortisone 85, 23–597 91, 30–346 0.99
Maternal Cortisol 5, 0–672 4, 1–79 0.001
 Cortisone 18, 2–87 18, 8–43 0.75
Values expressed as median, range in pg/mg.
*Analyzed with a paired t-test, performed with log-transformed GC concentrations.
Table 3 Associations of neonatal hair glucocorticoid concentrations directly postpartum with perinatal and maternal factors.
  β (95% CI) P value
Perinatal factors    
 Gestational age Cortisol 0.07 (0.04 to 0.10) <0.001
 Cortisone 0.04 (0.01 to 0.06) 0.004
 Gestational age (only term pregnancies) Cortisol 0.11 (0.07 to 0.16) <0.001
 Cortisone 0.04 (−0.001 to 0.08) 0.06
 Birth weight (kg) Cortisol 0.09 (−0.003 to 0.17) 0.06
 Cortisone 0.10 (0.03–0.17) 0.008
 Birth weight (s.d.) Cortisol 0.01 (−0.05 to 0.06) 0.79
 Cortisone 0.03 (−0.02 to 0.07) 0.23
 Male sex Cortisol 0.10 (−0.02 to 0.21) 0.09
 Cortisone 0.08 (−0.01 to 0.18) 0.07
 Delivery via cesarian section Cortisol −0.14 (−0.26 to −0.03) 0.015
 Cortisone −0.14 (−0.24 to −0.05) 0.003
 Perinatal infection (≥7 days antibiotics) Cortisol 0.17 (0.06–0.29) 0.003
 Cortisone 0.22 (0.13–0.31) <0.001
 Respiratory problems Cortisol −0.07 (−0.28 to 0.13) 0.47
 Cortisone −0.06 (−0.22 to 0.11) 0.52
Maternal factors    
 Age Cortisol −0.01 (−0.02 to 0.01) 0.31
 Cortisone 0.00 (−0.01 to 0.01) 0.82
 Ethnicity Cortisol −0.04 (−0.15 to 0.08) 0.55
 Cortisone −0.09 (−0.16 to 0.01) 0.07
 Maternal smoking Cortisol −0.09 (−0.18 to 0.003) 0.06
 Cortisone −0.09 (−0.43 to 0.26) 0.62
 Parity Cortisol −0.26 (−0.36 to −0.16) <0.001
 Cortisone −0.07 (−0.17 to 0.02) 0.12
 Hypertensive disorders Cortisol −0.02 (−0.25 to 0.21) 0.85
 Cortisone −0.15 (−0.33 to 0.04) 0.12
Values represent log-transformed β (95% confidence interval) as calculated with linear regression.
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between gestational age and neonatal hair GCs is also still 
present in term neonates, another mechanism appears to 
be present as well. Induction of labor has been suggested 
to be partly due to an increase in cortisol, which occurs 
in all species studied to date and which promotes fetal 
organ maturation (7, 24). This increase in cortisol is 
thought to be due to a positive feedback loop established 
between placenta-derived CRH and cortisol originating 
from the fetal adrenals (6, 25), which can only be broken 
by the severance of the umbilical cord. Fetal distress may 
accelerate this feedback loop (8), which might explain the 
increased hair GC levels in neonates who are treated for a 
perinatal infection.
It is as of yet unknown whether neonatal hair GC 
levels fully result from fetal cortisol production or whether 
the transplacental supply of cortisol might also contribute 
to neonatal GC levels in hair. Previous research has 
suggested that cortisol is transferred via the placenta to 
the fetus, although most cortisol is inactivated to cortisone 
by placental 11β-hydroxysteroid dehydrogenase type 2 
(11βHSD2) (8). However, as maternal serum cortisol levels 
are 10 times higher than fetal serum levels, even small 
amounts of cortisol could account for about 40% of the 
variance in fetal concentrations (4). In our study, we found 
a positive correlation between maternal and neonatal 
hair cortisol levels, but not with cortisone. The positive 
correlation between neonatal and maternal hair cortisol 
levels might therefore be a reflection of placental transfer. 
However, this does not explain why the neonatal hair GC 
levels were much higher compared to maternal levels. 
We speculate that this may be due to differences in hair 
growth and structure between the fetus and its mother.
While it is feasible that cortisol in neonatal hair is 
derived from hair follicles, where it is incorporated after 
diffusion from blood (14), cortisol in amniotic fluid 
might contribute to the GC concentrations measured in 
hair. Moreover, although hair growth in utero is roughly 
known, the specifics are still unclear. The first stage of hair 
growth starts during the 15th week of gestation, and by 
week 18–20, the entire scalp is covered with hair in the 
primary, anagen stage. Next, between week 24 and 28, 
the anagen hair converts into telogen hair via a catagen 
phase (26). Hair growth, as well as the conversion to 
more mature hair, is region-specific and dependent on 
several biochemical and individual variations (26, 27, 
28). Whether hair in the anagen phase already contains 
GCs, or whether the accumulation of GCs occurs at a 
later phase, is unknown. Therefore, although it is thought 
that neonatal hair reflects at least the third trimester of 
pregnancy (26), the true time window which is represented 
by GCs measured in hair is not known. Since perinatal 
infection and mode of delivery also appear to influence 
hair GC levels, it is likely that the last stages of pregnancy 
have a significant contribution to GC levels measured 
in hair. Future studies should include measurements of 
growth velocity of neonatal hair.
Our study showed significantly increased GC levels 
in neonatal hair compared to maternal hair at the OPV 
(44 ± 11  days postpartum), although a decrease between 
birth and the OPV was observed in cortisol levels. This 
suggests that GC levels at the OPV represent a combination 
of intra- and extrauterine influences, supported by our 
finding that GC levels at the OPV are still associated 
with several perinatal factors. However, due to the 
Table 4 Associations of the course of neonatal hair glucocorticoid concentrations with perinatal and maternal factors.
  Effect on delta Effect on OPV values
  β (95% CI) P value β (95% CI) P value
Perinatal factors
Gestational age Cortisol −0.02 (−0.05 to 0.00) 0.08 0.08 (0.04 to 0.12) <0.001
Cortisone −0.006 (−0.013 to 0.001) 0.08 0.00 (−0.04 to 0.04) 0.87
Birth weight (in kg) Cortisol −0.05 (−0.12 to 0.02) 0.19 0.13 (0.003 to 0.26) 0.05
Cortisone −0.02 (−0.03 to 0.01) 0.15 0.00 (−0.12 to 0.12) 0.96
Male sex Cortisol 0.02 (−0.07 to 0.11) 0.68 0.19 (0.02 to 0.36) 0.03
Cortisone −0.01 (−0.03 to 0.02) 0.46 0.00 (−0.14 to 0.13) 0.99
Delivery via caesarian section Cortisol 0.06 (−0.04 to 0.16) 0.24 −0.06 (−0.25 to 0.13) 0.55
Cortisone 0.03 (0.01 to 0.05) 0.02 −0.08 (−0.23 to 0.08) 0.33
Perinatal infection (≥7 days antibiotics) Cortisol −0.06 (−0.15 to 0.04) 0.25 −0.04 (−0.22 to 0.14) 0.66
Cortisone −0.03 (−0.05 to −0.004) 0.02 0.12 (−0.03 to 0.27) 0.11
Maternal factors
Parity Cortisol 0.07 (−0.02 to 0.16) 0.11 −0.11 (−0.28 to 0.05) 0.18
 Cortisone  0.01 (−0.01 to 0.03)  0.32 0.01 (−0.13 to 0.14) 0.91
Values represent log-transformed β (95% confidence interval) as calculated with linear regression. All associations were corrected for age at the OPV.
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biochemical and individual variations in hair growth (26, 
27, 28), and since hair was only measured twice in this 
study, the contribution of intrauterine and extrauterine 
influences on hair GC levels at the OPV is unknown. We 
recommend to assess at which point of time intrauterine 
factors are no longer related to hair GC levels, since this 
might provide a clear view of early life influences on 
HPA axis development. Since hair GC levels appear to be 
moderately stable in the second half of the first year of life 
(29), intrauterine influences on hair GC levels most likely 
disappear within the first 6 months.
Our study has several strengths and limitations. First, 
GC analyses were performed using LC–MS/MS, which has 
high sensitivity. Hoffman and coworkers (18) measured 
hair cortisol levels with an immunoassay, which might 
explain the fact that they did not find an association 
between maternal and neonatal hair cortisol levels, and 
reported maternal and neonatal cortisol levels which were 
much higher compared to our results, since immunoassays 
are more sensitive to cross-reactivity than LC–MS/MS (30, 
31). Cross-reactivity is particularly important to take into 
account when researching newborns, as they have high 
concentrations of (precursors of) sex steroids and GCs 
(5), which are partly of maternal origin. Additionally, we 
measured cortisone as well as cortisol, which provides 
valuable knowledge due to the conversion of cortisol to 
cortisone by placental 11βHSD2 (8). Our database also 
allowed us to analyze a wide range of pre- and perinatal 
factors. One of the limitations of our study is that the 
participants might not represent a normal population, 
since the participants in our study had to be hospitalized 
>72 h. Additionally, there might be a selection bias at the 
OPV measurements due to losses to follow-up, although 
the number of participants was relatively high (67%). 
Finally, there was a discrepancy between mother and child 
in the time frame that the hair measurements represented. 
In mothers, only the last centimeter of hair was analyzed. 
As adult hair grows approximately 1 cm per month (20, 
21), these analyses are representative of only the last 
month of pregnancy. Neonatal hair was analyzed in its 
entirety and is therefore representative of the intrauterine 
period during which cortisol can be incorporated in hair. 
Correlations between GCs in maternal and neonatal hair 
should therefore be interpreted in this context.
In conclusion, our findings suggest that infant 
hair GCs reflect the third trimester increase in cortisol, 
which might be caused by the positive feedback loop, a 
placenta-driven phenomenon, represented by a positive 
association with GA. Between birth and 1.5  months 
postpartum, cortisol concentrations decrease sharply. 
At this time point, GC levels appear to reflect both the 
intra- and extrauterine period, since neonatal levels are 
significantly higher than maternal GC levels. Perinatal 
complications and maternal HPA axis activity had minor 
influences on infant hair GCs.
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